Human angiotensin II
Alternative Names: (Asp1-Ile5) angiotensin II; Angiotensin II (human); Delivert; TY 10721Latest Information Update: 11 Apr 2005
Price :
$50 *
At a glance
- Originator Toa Eiyo
- Developer Astellas Pharma; Toa Eiyo
- Class Angiotensins; Antineoplastics; Peptide fragments; Vasopressors
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Cancer
Most Recent Events
- 11 Apr 2005 Yamanouchi has merged with Fujisawa to form Astellas Pharma
- 28 Nov 2000 Profile reviewed but no significant changes made
- 17 Jul 1998 TY 10721 is now called human angiotensin II